Please login to the form below

Not currently logged in
Email:
Password:

KOL Engagement

This page shows the latest KOL Engagement news and features for those working in and with pharma, biotech and healthcare.

Harnessing the unrivalled power of key opinion leaders

Harnessing the unrivalled power of key opinion leaders

dissemination, yet many companies underestimate the true value of this engagement. ... Early stage KOL identification and engagement is demonstrably critical for pharma.

Latest news

More from news
Approximately 0 fully matching, plus 1 partially matching documents found.

Latest Intelligence

  • Engaging with your opinion leaders Engaging with your opinion leaders

    Of course you do. Are your company's KOL engagement processes conducive to this? ... medical affairs in the run-up to launch, and commissioned to deliver the first KOL mapping the company has undertaken.

  • Next-generation KOL intelligence Next-generation KOL intelligence

    Advances in KOL intelligence are delivering richer insights into clinical landscapes than ever before, better enabling pharma to meet the challenges of an increasingly competitive and complex environment for KOL engagement. ... Or are you new to KOL

  • Mapping KOL relationships Mapping KOL relationships

    Whether conducting your own KOL mapping or working with an agency, start by asking yourself: what would I do with the information gleaned? ... The resulting mapping will provide a wealth of insights that will make your KOL engagement programme specific

  • Sustaining relationships Sustaining relationships

    Every KOL has different interests and wants to be engaged in a different way. ... How can you ensure more effective KOL engagement? Many pharma companies are really good at working with KOLs.

More from intelligence
Approximately 0 fully matching, plus 4 partially matching documents found.

Latest from PMHub

  • PRMA Consulting Ltd

    Our tailored services include strategic market access, landscape assessments, payer and KOL engagement, value propositions, GVDs, evidence generation, real-world evidence, pricing and reimbursement strategy. ... Quality is at the heart of every

  • The pharma rising star and what they mean for your KOL strategy

    But here’s an idea: how about being ahead of the game? KOL engagement is essential in keeping abreast of medical developments, we understand that. ... They also care about bringing the best prospects to the fore to continue their work long after

  • Nobull Communications

    Traditional medcomms. Social engagement. Influencer engagement. KOL engagement. Public Relations. Website Development.

  • KOL engagement: Blending accessibility with reliability

    For pharma companies, the difficulty with  KOL engagement  is that a large number of digital immigrants are reaching out to digital natives – but not speaking the same language. Today’s  KOLs ... So simply ‘reaching out online’ is not enough

  • emotive. expands Medical Writing and Client Services teams

    She brings a breadth of knowledge in pre-launch strategy and tactical implementation, KOL development, patient engagement, disease awareness and CME programmes, working with both marketing and medical clients.

More from PMHub
Approximately 1 fully matching, plus 7 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Say Communications

Influencing positive behaviours and delivering change is what drives us, using thought leadership, education, social and professional engagement and compelling,...

Latest intelligence

Report: Achieving launch excellence in the challenging healthcare markets of today
Our in-depth report is based on original data and expert interviews, which coupled with our own experience, ensures we give you the best recommendations for achieving launch success in challenging...
What is blockchain and why should i care - Richard Springham
Four Health - Emerging Technologies The power of blockchain lies in the fact it can prove that a unique event occurred at a certain time with out the need to...
NHS medicines optimisation milestone
Steve How, Paul Midgley and Oli Hudson, of the Wilmington Healthcare Consulting Team, explore the implications of Adalimumab’s recent European patent expiry...

Infographics